Skin cancer is one of the most common cancers in the US, with melanoma accounting for the majority of skin cancer deaths ...
Prescient acquires Uptake, with a focus on exceptional client delivery and impact in the pharmaceutical and biotech industry ...
The Skin Health Alliance (SHA) has donated £140,000 to the British Skin Foundation (BSF) for research into skin health.
The new programme addresses the urgent unmet medical need for new therapies to tackle antibiotic-resistant infections ...
As pharma organisations invest extensively in creating engaging content, the onboarding process must not be overlooked.
Dystrophic Epidermolysis Bullosa Research Association (DEBRA) Research and the University Medical Center Groningen (UMCG), ...
Patient engagement is not optional in pharma – it’s integral. Meaningful partnerships with patients, caregivers and advocates ...
NanoSyrinx has announced the appointment of Thomas J Farrell as its new CEO.
Novartis has announced that ianalumab has received Breakthrough Therapy designation from the US FDA to treat Sjögren’s disease.
Learn how a next-generation approach to field training – powered by Generative AI (GenAI) and lifelike avatar simulations and ...
The financing includes new investors Pfizer Ventures and Apricot Capital, bringing the total capital raised to $100m ...
Novo Nordisk’s Wegovy (semaglutide injection) has received a new approval from the Medicines and Healthcare products ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results